20560 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Lipopolysaccharides
METHOD OF VITAL PULP THERAPY USING BIOACTIVE COMPOSITES
#2GRAM-NEGATIVE BACTERIA FOR USE IN THE PREVENTION AND TREATMENT OF DISEASE IN POULTRY
#3LIPOSOMAL FORMULATION AND USE IN A COMBINATION PRODUCT AS AN ANTI-TUMOUR THERAPY
#4NANOPARTICLE CONSTRUCTS FOR SYSTEMIC CO-DELIVERY OF ANTI-TUMOR AGENTS
#5LIPOPOLYSACCHARIDE FOR USE AS A MEDICAMENT
#6PROPHYLACTIC DRUG AND THERAPEUTIC DRUG FOR DIABETES-ASSOCIATED DEMENTIA
#7USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#8TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS
#9PEGYLATED LIPOSOMES AND METHODS OF USE
#10MULTIVALENT VACCINE COMPOSITIONS AND USES THEREOF
#11METHOD FOR TREATING METABOLIC DISORDERS BY ILEUM-TARGETED DELIVERY OF ENDOTOXIN SEQUESTRANT
#12METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS
#13COMBINATION OF TLR LIGANDS, COMPOUNDS LABELLING TUMORS FOR IMMUNE ATTACK, ANTI-CD40 ANTIBODIES AND INHIBITORS OF GLUTAMINE METABOLISM FOR TREATING CANCER
#14IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR
#15COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS
#16USE OF TLR4 MODULATOR IN THE TREATMENT OF COCCIDIOSIS
#17USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#18GLYCOLIPID COMPOSITIONS AND METHODS OF USE
#19TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS
#20USES OF LIPOTEICHOIC ACID FROM BIFIDOBACTERIA
#21COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS
#22CANCER CHEMOTHERAPY SUPPORTING AGENT, FOOD, AND DRUG
#23METHODS, COMPOSITIONS AND DEVICES FOR TREATING NEUROINFLAMMATORY CONDITIONS
#24Immunomodulatory lipopolysaccharide compositions
#25Medicine for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#26METHODS FOR IMPROVING ANTI-OXIDATION AND PREVENTING/TREATING DISEASES USING HYPO-ACYLATED LIPOPOLYSACCHARIDE
#27Pegylated liposomes and methods of use
#28METHOD FOR TREATING AMYLOIDOGENIC DISEASE
#29USE OF TOLL-LIKE RECEPTOR 2 (TLR-2) AGONIST FOR MODULATING HUMAN IMMUNE RESPONSE
#30EXTENDED RELEASE IMMUNOMODULATORY IMPLANT TO FACILITATE BONE MORPHOGENESIS
#31Multivalent vaccine compositions and uses thereof
#32POSITIVE LATENCY EFFECTS ON COCCIDIOSIS PREVENTION AND TREATMENT VIA ANIMAL FEED
#33COMPOSITIONS COMPRISING BACTERIAL STRAINS
#34IMMUNE PRIMING TO ACCELERATE/ENHANCE IMMUNE RESPONSE THROUGH ADMINISTRATION OF NATURAL IMMUNE MODULATOR
#35Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#36ANTICANCER AGENT, PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT, AND KIT
#37Composition for preventing or treating muscular diseases, or for improving muscular functions, containing ganglioside
#38A HIGH CAPACITY PLATFORM FOR IMMUNOGENIC CANCER CELL DEATH
#39LIPIDATED PSA COMPOSITIONS AND METHODS
#40Use of Immunomodulators to Control Infection and Stimulate Healing in Normal and Diabetic Wounds
#41METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS
#42GLUCOCEREBROSIDE TREATMENT OF DISEASE
#43Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response
#44NANOPARTICLE CONSTRUCTS FOR SYSTEMIC CO-DELIVERY OF ANTI-TUMOR AGENTS
#45Extended release immunomodulatory implant to facilitate bone morphogenesis
#46Extended release immunomodulatory implant to facilitate bone morphogenesis
#47GLUCOCEREBROSIDE TREATMENT OF DISEASE
#48Compositions comprising bacterial strains
#49Method of inhibiting inflammatory response using lipopolysaccharide of
#50Brain function-improving agent, food, and medicine using lipopolysaccharide
#51PEGylated liposomes and methods of use
#52Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
#53Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#54Composition for inhibiting survival or growth of tubercle bacillus by adjusting polarization of macrophage, and method using same
#55Immune modulator and vaccine composition containing the same
#56Glycolipid compositions and methods of use
#57Methods of treating cancer
#58Sphingamide compounds and methods for binding iNKT cells
#59Composition for enhancing immunity comprising immune modulator and cationic liposome, and use of same
#60COMPOUND OR SALT THEREOF, ANTI-INFLAMMATORY AGENT, ANTI-CANCER AGENT AGAINST LUNG CANCER, METHOD OF PRODUCING COMPOUND OR SALTS THEREOF, METHOD OF TREATING INFLAMMATORY DISEASES AND METHOD OF TREATING LUNG CANCER
#61IMMUNOMODULATORY EFFECT OF INHALED KINASE INHIBITOR PEPTIDES IN LUNG
#62Compositions comprising bacterial strains
#63Methods for generating macrophages with enhanced cancer phagocytosis
#64Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6
#65Artificial invaplex formulated with deacylated lipopolysaccharide
#66IMMUNOSTIMULATORY COMBINATIONS
#67Glucocerebroside treatment of disease
#68Lipidated PSA compositions and methods
#69GM3-promoted inflammation inhibitor and inflammatory cytokine production inhibitor
#70Method for treating hemolytic uremic syndrome
#71Core constructs and their uses in configuring pharmaceutical molecules
#72Anti-cancer agent comprising HVJ-E and CXCL2
#73COMPOSITION AND METHOD FOR INDUCING ANTI-INFLAMMATORY RESPONSE
#74Allergy vaccine composition
#75Compositions comprising bacterial strains
#76Compositions comprising bacterial strains
#77GLUCOCEREBROSIDE TREATMENT OF DISEASE
#78Glucocerebroside treatment of liver disorders
#79Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#80CHEMOREPULSION OF CELLS
#81MODULATION OF CHRFAM7A FOR ANTI-INFLAMMATORY THERAPIES
#82Therapy-enhancing glucan
#83Vaccine adjuvant compositions
#84Compositions comprising bacterial strains
#85Pharmaceuticals in joint-linker configurations for treating pathological blood clots
#86METHODS OF TREATING NECROTIZING ENTEROCOLITIS BY ADMINISTERING NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS,TLR9 AGONISTS AND TLR4 ANTAGONISTS
#87Molecular constructs with targeting and effector moieties
#88Peptide core-based multi-arm linkers
#89Molecular constructs for treating tumors
#90Composition for Enhancing Transgene Expression in Eukaryotic Cells and Method for Enhancing Production of a Target Protein Encoded by a Transgene
#91SCAFFOLDS CONTAINING CYTOKINES FOR TISSUE ENGINEERING
#92IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NEOPLASIA
#93NOVEL HEMOGLOBIN-DERIVED PEPTIDE BASED PHARMACEUTICAL COMPOSITIONS
#94Immunostimulatory combinations
#95Method of attenuating reactions to skin irritants
#96Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#97Biomarker for detecting white matter stroke, containing toll-like receptor 2, and medical use of toll-like receptor 2
#98Immunotherapeutic potential of modified lipooligosaccharides/lipid A
#99T cell balance gene expression, compositions of matters and methods of use thereof
#100MIXTURE OF POLAR GLYCOLIPIDS FOR USE IN THE TREATMENT OF PAIN AND COPD
#101Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#102Methods of treating necrotizing enterocolitis by administering nuclear oligomerization domain-2 agonists,TLR9 agonists and TLR4 antagonists
#103Therapy-enhancing glucan
#104Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns
#105Lipid-containing PSA compositions, methods of isolation and methods of use thereof
#106BLOCKADE OF EOSINOPHIL PRODUCTION BY TOLL-LIKE RECEPTORS
#107Regulation of energy metabolism and obesity by modulating a proliferation-inducing ligand (APRIL) or APRIL signaling
#108VACCINE COMPOSITION FOR TRANSDERMAL OR MUCOSAL ADMINISTRATION
#109WT1 peptide cancer vaccine composition for transdermal administration
#110REMEDY
#111ADJUVANT COMPOSITIONS WITH 4-1BBL
#112REGULATION OF ENERGY METABOLISM AND OBESITY BY MODULATING B CELL ACTIVATING FACTOR (BAFF, BLYS) OR BAFF SIGNALING
#113TREATMENT OF MASTITIS
#114Methods for Treating and Preventing Cardiac Dysfunction in Septic Shock
#115USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
#116Methods for detecting antibody that specifically bind a siderophore receptor polypeptide
#117REMEDY
#118Therapy-enhancing glucan
#119Methods of treating cerebral amyloid angiopathy
#120Immunogenic compositions and methods for treating neoplasia
#121NGAL AND URINARY TRACT INFECTION
#122Immunotherapy comprising TLR9 ligand and CD40 ligand
#123Prevention And Treatment Of Amyloidogenic Disease
#124Method for treating amyloid disease
#125TLR 4 and 9 receptors agonists for preventing septic complications of post-traumatic immunodepression in patients hospitalized for severe traumatic injuries
#126Prevention and Treatment of Amyloidogenic Disease
#127Regulation of energy metabolism and obesity by modulating B cell activating factor (BAFF, BLYS) or BAFF signaling
#128Immunizing Compositions and Methods of Use
#129Immunizing compositions and methods of use
#130Lipopolysaccharide of ochrobactrum intermedium and their use as immunostimulant of mammalians
#131Use of toll-like receptor-9 agonists
#132Dendritic cell tumor injection (DCTI) therapy
#133Immunogenic compositions and diagnostic and therapeutic uses thereof
#134Glycolipid Mixture with Anti-Inflammatory Activity Obtained from Oscillatoria Planktothrix
#135IMMUNOSTIMULATORY COMBINATIONS
#136Rhamnolipid-based formulations
#137RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
#138Immunizing compositions and methods of use
#139Immunizing compositions and methods of use
#140Immunizing compositions and methods of use
#141Therapy-enhancing glucan
#142Methods for treating inflammatory bowel disease
#143Highly purified antiendotoxin compound
#144METHODS OF ACTIVATING NKT CELLS
#145Compositions comprising lipoteichoic acid for use in treating pleural effusion or pneumothorax
#146METHOD FOR THE IDENTIFICATION OF PATIENTS IN NEED OF THERAPY HAVING MINOR COGNITIVE DISORDERS AND THE TREATMENT OF SUCH PATIENTS
#147MODULATORS OF PARAPTOSIS AND RELATED METHODS
#148Ex vivo uses of immunostimulatory combinations
#149Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#150Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors
#151Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#152METHODS OF REDUCING THE SEVERITY OF MUCOSITIS
#153THERAPY-ENHANCING GLUCAN
#154Adjuvancy and immune potentiating properties of natural products of
#155THERAPY-ENHANCING GLUCAN
#156Chemorepulsion of cells
#157SYNTHETIC NUTRITIONAL FORMULATIONS
#158Remedy
#159NOVEL ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 4
#160Systems for modulating inflammation
#161Systems for modulating inflammation
#162Systems for modulating inflammation
#163Systems for modulating inflammation
#164Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
#165METHODS FOR ATTENUATING ALLERGEN-INDUCED AIRWAY HYPERREACTIVITY USING CD1D DEPENDENT ANTAGONISTS
#166Method of treating intrauterine inflammation
#167STEM CELL THERAPY FOR BLOOD VESSEL DEGENERATION
#168High affinity Siglec ligands
#169COMPOSITIONS FOR- DETECTING OF INFLUENZA VIRUSES AND KITS AND METHODS USING SAME
#170Prevention and treatment of amyloidogenic disease
#171Adjuvancy and immune potentiating properties of natural products of
#172Method for treating amyloid disease
#173Immunizing compositions and methods of use
#174Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
#175TLR9 agonist and CD40 agonist immunostimulatory combinations
#176GLYCOLIPIDS AND ANALOGUES THEREOF AS ANTIGENS FOR NK T CELLS
#177Immunizing compositions and methods of use
#178Dendritic cell tumor injection (DCTI) therapy
#179Humanized antibodies that recognize beta amyloid peptide
#180MODULATORS OF PARAPTOSIS AND RELATED METHODS
#181HUMANIZED ANTIBODIES THAT RECOGNIZE BETA AMYLOID PEPTIDE
#182Drug formulations for coating medical devices
#183Method of Attenuating Reactions to Skin Irritants
#184Methods for detection of lysosomal storage disease
#185Methods for detection of lysosomal storage disease
#186Use of penetration enhancers and barrier disruption methods to enhance the immune response of an antigen
#187PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#188Prevention and treatment of amyloidogenic disease
#189Humanized antibodies that recognize beta amyloid peptide
#190Pharmaceutical Composition Having Inhibitory Effect on Overproduction and Accumulation of Extracellular Matrix
#191CHEMOREPULSION OF CELLS
#192Rhamnolipid-based formulations
#193THERAPY-ENHANCING GLUCAN
#194Th1 cell differentiation accelerator
#195Compositions and methods for detection of lysosomal storage disease
#196PROPHYLACTIC AND THERAPEUTIC TREATMENT OF INFECTIOUS AND OTHER DISEASES WITH MONO- AND DISACCHARIDE-BASED COMPOUNDS
#197CHLAMYDIA VACCINES
#198PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASE
#199Compositions And Methods For Preventing And Treating Endotoxin-Related Diseases And Conditions
#200Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant
#201Humanized antibodies that recognize beta amyloid peptide
#202Glycosylphosphatidylinositol Glycan Signalling Via Integrins Functioning as Glycan Specific Receptors
#203Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
#204Treatment and prophylaxis of sepsis and septic shock
#205METHODS FOR TREATING LYMPHOCYTE-ASSOCIATED DISORDERS BY MODULATION OF SIGLEC ACTIVITY
#206Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase
#207Treatment and prophylaxis of sepsis and septic shock
#208Use of lipid conjugates in cystic fibrosis and applications thereof
#209Glucocerebroside treatment of pulmonary or respiratory diseases or disorders
#210Formulations for mediating inflammatory bowel disorders
#211Immunomodulatory methods using oligosaccharides
#212β glycolipids as immuno-modulators
#213Apolipoprotein E as an adjuvant for lipid antigens
#214Methods and means for inhibiting fever
#215Inhibitors of sporeforming pathogens and applications of the same
#216Methods and compositions for the prevention and regression of neovascularization
#217Sialidase inhibitors for the treatment of cardiovascular disease
#218Methods of reducing the severity of mucositis
#219Synthetic nutritional formulations
#220Methods of Treating A Bacterial Infection using F. Tularensis Lipopolysaccharide
#221Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock
#222Enhanced delivery of sphingolipids
#223Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
#224Method of treating patients with a mucinous glycoprotein (MUC-1) vaccine
#225Glucocerebroside treatment of liver disorders
#226Method for treating amyloid disease
#227Multibacterial vaccines and uses thereof
#228Methods for treating severe acute respiratory syndrome
#229Formulations for mediating inflammation and for reducing blood cholesterol
#230Nanoparticulate delivery systems for treating multi-drug resistance
#231Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding
#232Treatment of anemia
#233Compositions and methods for treating neurological disorders
#234Compositions and methods for preventing and treating endotoxin-related diseases and conditions
#235Dendritic cell tumor injection (DCTI) therapy
#236Use of lipid conjugates in the treatment of infection
#237Use of lipid conjugates in the treatment of infection
#238Use of lipid conjugates in the treatment of infection
#239Use of lipid conjugates in the treatment of infection
#240Therapy-enhancing glucan
#241Immune stimulating composition comprising bacterial chromosomal DNA fragments having methylated CpG sequences and non-toxic lipopolysaccharides
#242Methods for reducing fecal shedding
#243Therapy-enhancing glucan
#244Immunogenic compositions and diagnostic and therapeutic uses thereof
#245Anti-pneumococcal preparations
#246Remedy
#247Use of lipid conjugates in the treatment of infection
#248Methods of activating NKT cells
#249Methods for stimulating tlr irf3 pathways for inducing anti-microbial, anti-inflammatory and anticancer responses
#250Particle-bound human immunodeficiency virus envelope glycoproteins and related compositions and methods
#251Immunomodulatory methods using oligosaccharides
#252Adjuvancy and immune potentiating properties of natural products of
#253Prevention and treatment of amyloidogenic disease
#254Ceramide kinase and uses thereof
#255Prevention and treatment of amyloidogenic disease
#256Therapy-enhancing glucan
#257Prophylactic and therapeutic treatment of infectious and other diseases with mono-and disaccharide-based compounds
#258Compositions and methods for modulating an immune response
#259Co-encapsulated WT1 polypeptide and immunostimulant microsphere formulations and methods thereof
#260Prevention and treatment of amyloidogenic disease
#261Humanized antibodies that recognize beta amyloid peptide
#262Modulators of paraptosis and related methods
#263Treatment of inflammatory bowel disease
#264Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases
#265Use of an anti-endotoxin drug in the prevention and treatment of disease
#266Chylamydia vaccine
#267Ceramide formulations suitable for oral administration
#268Prevention and treatment of amyloidogenic disease
#269Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
#270Prevention and treatment of amyloidogenic disease
#271Prevention and treatment of amyloidogenic disease
#272Treatment of inflammatory bowel disease through induction of indoleamine 2.3-dioxygenase
#273Pharmaceutical compositions of safingol and methods of using the same
#274Ceramide de novo synthesis-based therapeutic and prophylactic methods, and related articles of manufacture
#275Immune stimulating and controlling composition comprising bacterial chromosomal DNA fragments and non-toxic lipopolysaccharides
#276Prevention and treatment of amyloidogenic disease
#277Treatment with agonists of toll-like receptors
#278Prevention and treatment of amyloidogenic disease
#279Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
#280Prevention and treatment of amyloidogenic disease
#281Prevention and treatment of amyloidogenic disease
#282Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix
#283Prevention and treatment of amyloidogenic disease
#284Agents and methods for treatment of disease by oligosaccharide targeting agents
#285Prevention and treatment of amyloidogenic disease
#286Prevention and treatment of amyloidogenic disease
#287Outer membrane vesicles from gram negative bacteria and use as a vaccine
#288Prevention and treatment of amyloidogenic disease
#289Glucocerebroside treatment of disease